Role of leukotriene B4 receptors in the interplay of inflammation and infection

描述（由申请人提供）：结肠癌是美国癌症相关死亡的主要原因。已知暴露于一些有害的环境因素和西方饮食的消费有助于恶性结肠癌的发病机制。虽然已知慢性炎症是肿瘤发展的主要促进因素，但肠道菌群在结肠癌发生中的作用尚不清楚。我们的实验室已经确定白三烯B4受体BLT1是炎症和宿主对感染反应的主要调节因子。在小鼠自发性肠癌（ApcMin/+）模型中，我们观察到BLT1的缺失极大地促进了肠道肿瘤的发展。这导致了一个中心假设，即缺乏BLT1通过缺陷免疫监视和/或改变肠道微生物稳态来促进结肠肿瘤的发展。缺乏促炎介质会增加炎症和肿瘤的发展，这一看似矛盾的结果表明，不断变化的肠道微环境可能对结直肠癌的发展产生重大影响。目前的提案将从三个具体目标来检验这一假设。在目的1中，我们将研究白三烯B4途径介导的ApcMin/+小鼠肠癌保护机制。目的2将建立在BLT1+/+和BLT1-/-小鼠背景下荷瘤小鼠的免疫功能。Aim 3将测试新的概念，即有缺陷的宿主反应和改变的肠道微生物群是导致BLT1-/-小鼠结肠肿瘤快速发展的原因。这些研究将提供一个全面的模型系统来检查炎症和感染对结肠癌发展的相互作用。由于小鼠ApcMin/+模型与人类结肠癌高度相关，其结果将对人类结肠癌的治疗产生直接和即时的影响。

DESCRIPTION (provided by applicant): Colon cancer is a leading cause of cancer related deaths in the United States. Exposure to a number of hazardous environmental agents and consumption of the Western diet are known to contribute to the pathogenesis of malignant colon cancer. While chronic inflammation is known to be a major promoter of tumor development the role of gut microflora in contributing to the colon cancer is unknown. Our laboratory has identified leukotriene B4 receptor, BLT1 as a major regulator of inflammation and host response to infections. In a mouse model of spontaneous intestinal cancer (ApcMin/+), we have made the observation that absence of BLT1 greatly enhances intestinal tumor development. This has led to the central hypothesis that Absence of BLT1 enhances colon tumor development by defective immune surveillance and/or altered microbial gut homeostasis. This apparently paradoxical result that loss of a proinflammatory mediator increases inflammation and tumor development suggests that the ever changing micro environment of intestine can have a major influence on the development of colorectal cancer. The current proposal will test this hypothesis in three specific aims. In aim 1, we will examine the mechanisms of leukotriene B4 pathway mediated protection of intestinal cancers in ApcMin/+ mice. Aim 2 will establish the immune functions in tumor bearing mice in the context of BLT1+/+ and BLT1-/- mice. Aim 3 will test the novel concept that defective host response and altered gut microbiota are responsible for rapid development of colon tumors in BLT1-/- mice. These studies will provide a comprehensive model system to examine the interplay of inflammation and infections to the development of colon cancer. Since the mouse ApcMin/+ model is highly related to human colon cancers the result will have direct and immediate impact for the treatment of human colon cancer.